放射線治療における高速中性子

Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.

Cancer research·1994

Neutron therapy at Hammersmith Hospital 1970 to 1985. A re-examination of results.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·1989

A comparison of clinical and laboratory data on neutron therapy for locally advanced tumors.

International journal of radiation oncology, biology, physics·1987

The implications of improved treatment of malignant salivary gland tumors by fast neutron radiotherapy.

International journal of radiation oncology, biology, physics·1987

Fast neutrons in the treatment of locally advanced breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·1987

A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydrocortisone creams in the treatment of eczema.

The Journal of international medical research·1987

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Electron nuclear dynamics of H+ + uracil at ELab = 1.47 and 4.00 keV: a prototype of ion cancer therapy reactions.

Physical chemistry chemical physics : PCCP·2026

Prone versus supine radiotherapy for right-sided breast cancer - a retrospective study of radiotherapy plans.

Radiation oncology (London, England)·2026

Dosimetric superiority of proton radiosurgery in liver cancer: an in silico comparative dosimetric study.

BMC cancer·2026

Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac.

European journal of nuclear medicine and molecular imaging·2026

Accelerated Partial Breast Irradiation Delivered with Helical Tomotherapy: Dosimetry and Volumetric Predictors of Ipsilateral Breast Dose.

Cancers·2026

Measuring reaction-in-flight neutrons via the activation technique.

The Review of scientific instruments·2026

関連する実験動画

放射線治療における高速中性子

関連する概念動画

Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.

Neutron therapy at Hammersmith Hospital 1970 to 1985. A re-examination of results.

A comparison of clinical and laboratory data on neutron therapy for locally advanced tumors.

The implications of improved treatment of malignant salivary gland tumors by fast neutron radiotherapy.

Fast neutrons in the treatment of locally advanced breast cancer.

A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydrocortisone creams in the treatment of eczema.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Electron nuclear dynamics of H<sup>+</sup> + uracil at <i>E</i><sub>Lab</sub> = 1.47 and 4.00 keV: a prototype of ion cancer therapy reactions.

Prone versus supine radiotherapy for right-sided breast cancer - a retrospective study of radiotherapy plans.

Dosimetric superiority of proton radiosurgery in liver cancer: an in silico comparative dosimetric study.

Predicting tumour and organ dose in α-radiopharmaceutical therapy: a <sup>89</sup>Zr-based dosimetric approach for <sup>225</sup>Ac.

Accelerated Partial Breast Irradiation Delivered with Helical Tomotherapy: Dosimetry and Volumetric Predictors of Ipsilateral Breast Dose.

Measuring reaction-in-flight neutrons via the activation technique.

関連する実験動画

放射線治療における高速中性子

関連する概念動画

関連記事